Smith Hunter C bought RYTM
February 11, 2026 · Form 4 insider transaction
Smith Hunter C bought 25,000 shares of Rhythm Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
25,000
Price
$0.00
Total value
N/A
InsiderSmith Hunter C
Role—
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 11, 2026
Filing dateFebruary 12, 2026
Shares owned after25,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.; The restricted stock units vest as to 25% of the total shares on each of February 1, 2027, February 1, 2028, February 1, 2029 and February 1, 2030. The restricted stock units have no expiration date.